Exogenous Fusarium Endophthalmitis: Clinical Features, Treatment Modalities, and Visual Outcomes
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.6.42 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Sujin Kang and 7 co-authors. Institution: Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States. Major MEDLINE topics: Endophthalmitis, Eye Infections, Fungal, Visual Acuity, Antifungal Agents. Cited 1 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
To characterize the clinical features, treatment modalities, and visual outcomes of culture-proven exogenous Fusarium endophthalmitis managed at a tertiary referral center.
Methods
This retrospective, single-center, consecutive case series included 14 eyes of 14 patients with culture-proven exogenous Fusarium endophthalmitis treated between October 2014 and December 2025. Diagnosis was confirmed by positive intraocular (aqueous or vitreous) cultures. Clinical records were reviewed for demographics, presenting characteristics, treatment course, complications, and visual and intraocular pressure outcomes.
Results
Median presenting best-corrected visual acuity (BCVA) was 2.40 logMAR (∼20/5000). Infection sources included trauma (7/14, 50%), anterior segment surgery (5/14, 36%), and contact lens-associated fungal keratitis (2/14, 14%). All eyes required combined antifungal therapy (topical, intravitreal, intracameral, and/or intrastromal with systemic treatment) and surgical intervention, including therapeutic penetrating keratoplasty (14/14, 100%) and vitrectomy (8/14, 57%). Median follow-up was 594 days. Median BCVA at last follow-up remained poor at 2.25 logMAR (∼20/3600), with four of 14 patients (29%) achieving ≥20/400 vision and three of 14 patients (21%) having light perception or no light perception. Complications occurred in 10 of 14 eyes (71%), most commonly ocular hypertension or secondary glaucoma (8/10, 80%) and retinal detachment (3/10, 30%). No eyes required enucleation or evisceration.
Conclusions
Exogenous Fusarium endophthalmitis is a serious ocular infection requiring multimodal therapy and multiple surgical interventions, yet long-term visual outcomes remain poor. Early fungal recognition and prompt antifungal treatment may improve outcome.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States.
- Ocular Microbiology Laboratory, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States.
Cite
APA
Kang, S., Smiddy, W. E., Yannuzzi, N. A., Albini, T. A., Miller, D., Amescua, G., Yoo, S. H., & Flynn, H. W. (2026). Exogenous Fusarium Endophthalmitis: Clinical Features, Treatment Modalities, and Visual Outcomes. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.6.42
Vancouver
Kang S, Smiddy WE, Yannuzzi NA, Albini TA, Miller D, Amescua G, et al. Exogenous Fusarium Endophthalmitis: Clinical Features, Treatment Modalities, and Visual Outcomes. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.6.42
BibTeX
@article{Kang2026,
author = {Kang, Sujin and Smiddy, William E and Yannuzzi, Nicolas A and Albini, Thomas A and Miller, Darlene and Amescua, Guillermo and Yoo, Sonia H and Flynn, Harry W},
title = {Exogenous Fusarium Endophthalmitis: Clinical Features, Treatment Modalities, and Visual Outcomes},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.6.42}
}
EUVIMED